| |
|
|
|
|
|
|
|||
|
BRIEF REPORT
From the Departments of Internal Medicine and
Physiology, University of Kentucky Medical Center; and the Veterans
Administration Hospital, Lexington, KY.
Cells in murine muscle have been reported to differentiate into
hematopoietic stem and progenitor cells and thus repopulate the
hematopoietic system of an irradiated animal. This activity was
attributed to muscle stem cells. We used an in vitro and in vivo
approach to identify the hematopoietic repopulating activity found in
muscle tissue of mice by antibody staining and cell sorting. We
confirmed existence of a hematopoietic repopulating cell in muscle tissue, but the data strongly suggest that repopulation is due
not to muscle stem cells but to hematopoietic cells present in muscle
tissue. Unexpectedly, the blood-forming cells were enriched in muscle
relative to their frequency in peripheral blood.
(Blood. 2002;100:721-723) An emerging theme in stem cell biology is the
flexibility or "plasticity" retained by adult stem cells such as
hematopoietic and neural stem cells to express differentiation programs
appropriate to specific tissue microenvironments.1-3
Plasticity was also ascribed to skeletal muscle stem cells, which were
reported to differentiate into hematopoietic stem cells when
transplanted into lethally irradiated animals.4-6 To
investigate the developmental potential and plasticity of cells in
skeletal muscle, we sorted cells derived from murine muscle tissue on
the basis of expression of surface markers found on hematopoietic
cells, endothelial cells, and muscle stem and progenitor cells. The
potential of stem and progenitor cells was analyzed in vitro by using a
cobblestone area-forming cell (CAFC) assay originally described for
studying hematopoietic cells7 and in vivo by using a
transplantation assay.
Mice
Muscle cell preparation
CAFC assay The CAFC assay was performed without modification as described previously for assessment of hematopoietic cells.7Transplantation Transplant-recipient female mice were given antibiotics in drinking water 1 week before irradiation. The mice received a dose of 9 Gy (11 Gy in 1 experiment) at least 4 hours before transplantation (11 Gy was split into 2 doses). In case of competitive transplantation, the competitor cells were of the same genotype as the recipient.Flow cytometry Cell suspensions were stained with antibodies according to standard procedures. The analyses were performed on either a FACS Vantage or FACScan device (BD Biosciences). The following antibodies (all from BD Biosciences) were used: CD5 (53-7.3), B220 (RA3-6B2), Mac-1 (M1/70), CD8a (53-6.7), Gr-1 (RB6-8C5), TER-119, c-Kit (2B8), Sca-1 (E13-161.7), Thy1.2 (30-H12), CD34 (RAM34), and CD31 (Mec13.1).
The expression patterns of hematopoietic epitopes on
muscle-derived cells were analyzed by flow cytometry (Figure
1A). Although the mice were perfused with
10 times their blood volume to remove contaminating peripheral blood, a
high percentage of muscle-derived cells expressed hematopoietic cell
markers, including CD45 (29%), in agreement with the findings of
McKinney-Freeman et al8; and B220 (26%), in contrast to
the results of Gussoni et al.4 The high percentage of
cells positive for Thy-1.2 (53%), an epitope found mostly on T cells,
is intriguing, because few CD8+ cells were
detectable.
Next, using a CAFC assay, we tested the in vitro stem and
progenitor cell potential of sorted muscle-derived cell populations and
determined the frequencies of CAFCs in muscle cell populations positive
(+) and negative ( CD34+ cells, reported to be muscle stem and progenitor
cells,9 did not generate cobblestone areas. Embryonic
endothelial cells (CD31+) have the potential to
differentiate into hematopoietic cells.10 We detected a
high frequency of CAFCs in muscle cells positive for CD31. However,
because of their low abundance, the CD31+ population
accounted for only half of the total number of CAFCs in the
muscle-derived cell suspension (data not shown). The remainder of the
CAFC-forming activity was found in CD45+ cells. We also
noted that the staining and sorting manipulations reduced CAFC activity
to almost 25% that in unstained cells. Cells with in vitro myogenic
activity were enriched in the CD45 The ability of distinct muscle-derived cell populations to repopulate the hematopoietic system of irradiated mice was analyzed in a transplantation assay (Figure 1D). Cells were sorted according to regions used for the CAFC assays (Figure 1B) and subsequently transplanted into lethally irradiated Ly5.1-Ly5.2 mismatched mice, and in some cases, admixed with recipient-type BM competitor cells.5,11 Mice given transplants of unstained muscle-derived cells showed long-term (> 8 months) multilineage repopulation and chimerism in secondary BM transplants, confirming the presence of stem cell activity (data not shown). Spleen chimerism reflected the percentage found in peripheral blood (Figure 1D), whereas donor chimerism in the thymus and BM was typically 10% to 20% of the percentage observed in the periphery (data not shown). Interestingly, even in mice showing multilineage reconstitution, most donor-derived cells in peripheral blood were Thy-1+, a feature also reported, but not emphasized, by Kawada and Ogawa.12 We detected the same Thy-1 skewing when white blood cells (WBCs) were used as donor cells, in accordance with a previous study of mobilized peripheral blood cells.13 Muscle-derived cells with the ability to repopulate the hematopoietic
compartment were Sca-1 Taken together, the Thy-1 skewing characteristic of repopulation from
peripheral blood progenitors and the surface phenotype of the
repopulating cell indicate a peripheral hematopoietic stem cell as the
repopulating unit. This conclusion is in agreement with observations by
Kawada and Ogawa12 and McKinney-Freeman et
al.8 In contrast to the findings of McKinney-Freeman et al, however, we detected the repopulating activity in the
Sca-1 As shown in Figure 1C and D, peripheral WBCs also contained CAFCs and repopulating activity. Transplantation of 2.5 × 106 muscle-derived cells, the number we obtained on average from a C57BL/6 mouse, resulted in a chimerism of 8% (Figure 1D). This is 16-fold higher than the chimerism obtained with 1.2 × 105 WBCs (0.5%), which correspond to 55 µL of blood. Indeed, to achieve the same percentage of chimerism observed after transplantation of muscle cells derived from a single mouse would require WBCs derived from 900 µL of blood. This suggests that these repopulating cells are not contaminating stem cells found in peripheral blood. Given that we obtained on average 1.8 × 106 muscle-derived cells from a DBA/2 mouse, the CAFC activity in muscle tissue dissected from one animal would be contained in 1.8 mL of blood (Figure 1C). Thus, we found that skeletal muscle tissue is enriched for hematopoietic stem cells. Further analyses will identify the location of these cells in muscle and determine whether they are sequestered in the wall of the vasculature or within the muscle tissue itself. Since this manuscript was submitted for publication, McKinney-Freeman et al8 reported that muscle-derived hematopoietic stem cells are hematopoietic of origin, a finding supported by our analyses.
Submitted November 6, 2001; accepted March 12, 2002.
Supported by National Institutes of Health grant AG16653 (G.V.Z.) and a fellowship of the Deutsche Akademie der Naturforscher Leopoldina funded by the Bundesministerium für Bildung und Forschung (H.G.).
The publication costs of this article were defrayed in part by page charge payment. Therefore, and solely to indicate this fact, this article is hereby marked "advertisement" in accordance with 18 U.S.C. section 1734.
Reprints: Hartmut Geiger, Division of Hematology/Oncology, Departments of Internal Medicine and Physiology, University of Kentucky Medical Center, 800 Rose Street, Lexington KY, 40536-0093; e-mail: ghart2{at}uky.edu.
1. Lagasse E, Connors H, Al-Dhalimy M, et al. Purified hematopoietic stem cells can differentiate into hepatocytes in vivo. Nat Med. 2000;6:1229-1234[CrossRef][Medline] [Order article via Infotrieve].
2.
Clarke DL, Johansson CB, Wilbertz J, et al.
Generalized potential of adult neural stem cells.
Science.
2000;288:1660-1663 3. Orlic D, Kajstura J, Chimenti S, et al. Bone marrow cells regenerate infarcted myocardium. Nature. 2001;410:701-705[CrossRef][Medline] [Order article via Infotrieve]. 4. Gussoni E, Soneoka Y, Strickland CD, et al. Dystrophin expression in the mdx mouse restored by stem cell transplantation. Nature. 1999;401:390-394[CrossRef][Medline] [Order article via Infotrieve]
5.
Jackson KA, Mi T, Goodell MA.
Hematopoietic potential of stem cells isolated from murine skeletal muscle.
Proc Natl Acad Sci U S A.
1999;96:14482-14486
6.
Pang W.
Role of muscle-derived cells in hematopoietic reconstitution of irradiated mice.
Blood.
2000;95:1106-1108
7.
de Haan G, Nijhof W, Van Zant G.
Mouse strain-dependent changes in frequency and proliferation of hematopoietic stem cells during aging: correlation between lifespan and cycling activity.
Blood.
1997;89:1543-1550
8.
McKinney-Freeman SL, Jackson KA, Camargo FD, Ferrari G, Mavilio F, Goodell MA.
Muscle-derived hematopoietic stem cells are hematopoietic in origin.
Proc Natl Acad Sci U S A.
2002;99:1341-1346
9.
Beauchamp JR, Heslop L, Yu DS, et al.
Expression of CD34 and Myf5 defines the majority of quiescent adult skeletal muscle satellite cells.
J Cell Biol.
2000;151:1221-1234 10. Nishikawa SI, Nishikawa S, Kawamoto H, et al. In vitro generation of lymphohematopoietic cells from endothelial cells purified from murine embryos. Immunity. 1998;8:761-769[CrossRef][Medline] [Order article via Infotrieve]. 11. Harrison DE, Jordan CT, Zhong RK, Astle CM. Primitive hemopoietic stem cells: direct assay of most productive populations by competitive repopulation with simple binomial, correlation and covariance calculations. Exp Hematol. 1993;21:206-219[Medline] [Order article via Infotrieve].
12.
Kawada H, Ogawa M.
Bone marrow origin of hematopoietic progenitors and stem cells in murine muscle.
Blood.
2001;98:2008-2013
13.
Szilvassy SJ, Meyerrose TE, Ragland PL, Grimes B.
Differential homing and engraftment properties of hematopoietic progenitor cells from murine bone marrow, mobilized peripheral blood, and fetal liver.
Blood.
2001;98:2108-2115
© 2002 by The American Society of Hematology.
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
![]() |
H. Xu, S. Eleswarapu, H. Geiger, K. Szczur, D. Daria, Y. Zheng, J. Settleman, E. F. Srour, D. A. Williams, and M.-D. Filippi Loss of the Rho GTPase activating protein p190-B enhances hematopoietic stem cell engraftment potential Blood, October 22, 2009; 114(17): 3557 - 3566. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Kohler, V. Schmithorst, M.-D. Filippi, M. A. Ryan, D. Daria, M. Gunzer, and H. Geiger Altered cellular dynamics and endosteal location of aged early hematopoietic progenitor cells revealed by time-lapse intravital imaging in long bones Blood, July 9, 2009; 114(2): 290 - 298. [Abstract] [Full Text] [PDF] |
||||
![]() |
Z. Xing, M. A. Ryan, D. Daria, K. J. Nattamai, G. Van Zant, L. Wang, Y. Zheng, and H. Geiger Increased hematopoietic stem cell mobilization in aged mice Blood, October 1, 2006; 108(7): 2190 - 2197. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Rosu-Myles, E. Stewart, J. Trowbridge, C. Y. Ito, P. Zandstra, and M. Bhatia A unique population of bone marrow cells migrates to skeletal muscle via hepatocyte growth factor/c-met axis J. Cell Sci., October 1, 2005; 118(19): 4343 - 4352. [Abstract] [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Copyright © 2002 by American Society of Hematology Online ISSN: 1528-0020 | |||||||||